Angiogenesis: A link to Thrombosis in Athero-thrombotic Disease
- 1 December 2003
- journal article
- review article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 33 (5-6) , 241-248
- https://doi.org/10.1159/000083809
Abstract
New insights to explain the clinical manifestations of atherosclerosis have resulted in a paradigm in which thrombosis is the major cause of acute coronary syndromes, peripheral arterio-vascular disease and stroke. Major efforts have been directed toward developing drugs to reduce thrombin and fibrin formation. Recent studies support a central role for angiogenesis of the atherosclerotic plaque in promoting atherothrombosis. The findings, in the face of efforts to use angiogenic agents to enhance vascular function, underline the challenge in treating atherothrombotic disease.Keywords
This publication has 45 references indexed in Scilit:
- Vascular Endothelial Growth Factor Gene Transfer Inhibits Neointimal Macrophage Accumulation in Hypercholesterolemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injuryJournal of Vascular Surgery, 2004
- Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial TissueHuman Gene Therapy, 2003
- Dietary Lipid Lowering Modifies Plaque Phenotype in Rabbit Atheroma After AngioplastyCirculation, 2003
- Oxidant stress: a key determinant of atherothrombosisBiochemical Society Transactions, 2003
- Extracellular Mediators in Atherosclerosis and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animalsMedical Molecular Morphology, 2002
- Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide SynthesisCirculation, 2002
- In this issueNature Reviews Drug Discovery, 2002
- Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary AtherosclerosisThe American Journal of Pathology, 2001